gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · SRTSHealthcareSurgical Instruments

Sensus Healthcare, Inc (SRTS)

$3.25−1.07%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$3.17▲ 2.26% in range
Nov 3, 2025Low $2.69 · High $5.30Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Sensus Healthcare closed at $3.25 on Nov 4, down 1.07%, 38.7% below its 52-week closing high. Volume of 474.0K shares was 0.93× its 20-day average (close to normal).

Split-adjusted performance: +9.4% over one month, -20.5% over six months, +4.8% over one year.

In the quarter ended Jun 30, 2026, revenue was $2.29M, down 68.7% from a year earlier, with a net margin of -382.1%.

Short interest was 229.9K shares at the Oct 15 settlement, up 1.0% from the prior report (1.7% of float, 14.3 days to cover).

Market cap$53.5M16.5M shares
Revenue · quarter$2.3M−68.7% YoY
Diluted EPS$-0.53—
P/E · TTM—P/S 3.1×
Net margin-382.1%Gross 33.6%
Dividend yieldNone
52-week range2.69 – 5.30−38.7% from high
Volume474.0K0.93× 20-day avg
Volatility · 60d55.5%Annualised
Short % of float1.7%14.3 days to cover
Net cash$15.2MCash $15.2M
Next earnings—Not scheduled
Split-adjusted performance
1W +15.2%1M +9.4%3M +9.1%6M −20.5%YTD −18.3%1Y +4.8%3Y +44.4%5Y −17.3%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum35
Revenue growth1
Net margin14
Value (low P/E)—
Size34

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short229.9K+1.0% vs prior
Days to cover14.3Settled Oct 15
% of float1.7%
Short vol. 10d38.5%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
SRTSSensus Healthcare$3.25−1.07%−20.5%−68.7%−382.1%—$53.5M
DXRDaxor$8.91+2.44%−12.1%+2.3%−403.2%—$52.0MCompare
SNWVSANUWAVE Health$5.73−3.37%−64.0%−3.1%−7.0%3.4$49.3MCompare
MDAISpectral AI$1.53+2.00%−31.1%−30.4%−118.5%—$49.2MCompare
CVRXCVRx$1.58+14.49%−77.7%+15.6%−89.4%—$42.1MCompare
XTNTXtant Medical Holdings$0.2960+6.47%−48.7%−35.0%−40.9%—$41.5MCompare
LNSRLENSAR$5.84+4.85%+8.4%+18.4%10.7%4.6$71.7MCompare
SKINSkinHealth Systems$11.05+6.76%−40.8%−7.8%−3.7%—$72.0MCompare
TELATELA Bio$0.8378+4.46%−15.4%−4.5%−58.4%—$37.8MCompare

News about Sensus Healthcare

All news →

No recent articles focused on Sensus Healthcare.

Quick answers

What does Sensus Healthcare do?
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids.
What is SRTS's market cap?
$53.50M, based on the Nov 4 close of $3.25.
Does Sensus Healthcare pay a dividend?
No regular cash dividend has been paid in the last year.
How much of SRTS is sold short?
229.9K shares, 1.7% of float, as of Oct 15, 2026.
What sector is SRTS in?
Healthcare, in the Surgical Instruments industry.

About Sensus Healthcare

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

HQ: Boca Raton, FL60 employeesListed Jul 25, 2016sensushealthcare.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology